Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

More on Causal Inference Studies.

Lederer DJ, Bell SC, Smyth AR, Chalmers JD.

Ann Am Thorac Soc. 2019 Feb 11. doi: 10.1513/AnnalsATS.201901-070LE. [Epub ahead of print] No abstract available.

PMID:
30742489
2.

Challenges in severe community-acquired pneumonia: a point-of-view review.

Torres A, Chalmers JD, Dela Cruz CS, Dominedò C, Kollef M, Martin-Loeches I, Niederman M, Wunderink RG.

Intensive Care Med. 2019 Feb;45(2):159-171. doi: 10.1007/s00134-019-05519-y. Epub 2019 Jan 31. Review.

PMID:
30706119
3.

British Thoracic Society guideline for bronchiectasis in adults.

Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn JS, Floto RA, Grillo L, Gruffydd-Jones K, Harvey A, Haworth CS, Hiscocks E, Hurst JR, Johnson C, Kelleher WP, Bedi P, Payne K, Saleh H, Screaton NJ, Smith M, Tunney M, Whitters D, Wilson R, Loebinger MR.

BMJ Open Respir Res. 2018 Dec 28;5(1):e000348. doi: 10.1136/bmjresp-2018-000348. eCollection 2018.

4.

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.

Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE.

Lancet Respir Med. 2019 Jan 15. pii: S2213-2600(18)30427-2. doi: 10.1016/S2213-2600(18)30427-2. [Epub ahead of print] Erratum in: Lancet Respir Med. 2019 Jan 25;:.

PMID:
30658914
5.

The evolution of the European Respiratory Journal: volume 2.

Chalmers JD, Kolb M.

Eur Respir J. 2019 Jan 17;53(1). pii: 1802459. doi: 10.1183/13993003.02459-2018. Print 2019 Jan. No abstract available.

PMID:
30655453
6.

British Thoracic Society Guideline for bronchiectasis in adults.

Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn SJ, Floto AR, Grillo L, Gruffydd-Jones K, Harvey A, Haworth CS, Hiscocks E, Hurst JR, Johnson C, Kelleher PW, Bedi P, Payne K, Saleh H, Screaton NJ, Smith M, Tunney M, Whitters D, Wilson R, Loebinger MR.

Thorax. 2019 Jan;74(Suppl 1):1-69. doi: 10.1136/thoraxjnl-2018-212463. No abstract available.

PMID:
30545985
7.

The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD.

Flynn RWV, MacDonald TM, Chalmers JD, Schembri S.

Respir Res. 2018 Dec 12;19(1):249. doi: 10.1186/s12931-018-0960-3.

8.

Economic burden of bronchiectasis in Germany.

Diel R, Chalmers JD, Rabe KF, Nienhaus A, Loddenkemper R, Ringshausen FC.

Eur Respir J. 2018 Dec 5. pii: 1802033. doi: 10.1183/13993003.02033-2018. [Epub ahead of print]

PMID:
30523162
9.

New Insights Into the Epidemiology of Bronchiectasis.

Chalmers JD.

Chest. 2018 Dec;154(6):1272-1273. doi: 10.1016/j.chest.2018.08.1051. No abstract available.

PMID:
30526964
10.

ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training.

Aliberti S, Farr A, Tabin N, Blasi F, Torres A, Woodhead M, Migliori GB, Sotgiu G, Dimopoulos G, Chalmers JD, Ringshausen FC, Loebinger MR, Read R, Rohde G.

Breathe (Sheff). 2018 Dec;14(4):269-275. doi: 10.1183/20734735.026218.

11.

Quality control for multiple breath washout tests in multicentre bronchiectasis studies: Experiences from the BRONCH-UK clinimetrics study.

O'Neill K, Lakshmipathy GR, Ferguson K, Cosgrove D, Hill AT, Loebinger MR, Carroll M, Chalmers JD, Gatheral T, Johnson C, DeSoyza A, Hurst JR, Bradbury I, Elborn JS, Bradley JM.

Respir Med. 2018 Dec;145:206-211. doi: 10.1016/j.rmed.2018.10.030. Epub 2018 Nov 1.

PMID:
30509710
12.

A comprehensive approach to lung function in bronchiectasis.

Radovanovic D, Santus P, Blasi F, Sotgiu G, D'Arcangelo F, Simonetta E, Contarini M, Franceschi E, Goeminne PC, Chalmers JD, Aliberti S.

Respir Med. 2018 Dec;145:120-129. doi: 10.1016/j.rmed.2018.10.031. Epub 2018 Nov 2.

PMID:
30509700
13.

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration.

Aliberti S, Polverino E, Chalmers JD, Altenburg J, Shteinberg M, Goeminne PC, Welte T, Shoemark A, Almagro M, Blasi F; EMBARC Clinical Research Collaboration.

Eur Respir J. 2018 Nov 29;52(5). pii: 1802074. doi: 10.1183/13993003.02074-2018. Print 2018 Nov. No abstract available.

PMID:
30498055
14.

Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial.

Chalmers JD, Djamin RS, Schouten M, Keir HR, Tan B, Aerts JGJV, Huang JT, van der Eerden M.

ERJ Open Res. 2018 Nov 12;4(4). pii: 00136-2018. doi: 10.1183/23120541.00136-2018. eCollection 2018 Oct.

15.

Bronchiectasis.

Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ.

Nat Rev Dis Primers. 2018 Nov 15;4(1):45. doi: 10.1038/s41572-018-0042-3. Review.

PMID:
30442957
16.

How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis.

Terranova L, Oriano M, Teri A, Ruggiero L, Tafuro C, Marchisio P, Gramegna A, Contarini M, Franceschi E, Sottotetti S, Cariani L, Bevivino A, Chalmers JD, Aliberti S, Blasi F.

Int J Mol Sci. 2018 Oct 20;19(10). pii: E3256. doi: 10.3390/ijms19103256.

17.

Distinct 'Immuno-Allertypes' of Disease and High Frequencies of Sensitisation in Non-Cystic-Fibrosis Bronchiectasis.

Mac Aogáin M, Tiew PY, Lim AYH, Low TB, Tan GL, Hassan T, Ong TH, Pang SL, Lee ZY, Gwee XW, Martinus C, Sio YY, Matta SA, Ong TC, Tiong YS, Wong KN, Narayanan S, Bijin Au V, Marlier D, Keir HR, Tee A, Abisheganaden JA, Koh MS, Wang Y, Connolly JE, Chew FT, Chalmers JD, Chotirmall SH.

Am J Respir Crit Care Med. 2018 Sep 28. doi: 10.1164/rccm.201807-1355OC. [Epub ahead of print]

PMID:
30265843
18.

A systematic review of clinical trial registration in major respiratory journals 2010-2018.

Suntila NSM, Smith A, Al-Dabbagh Y, Chalmers JD.

Eur Respir J. 2018 Dec 6;52(6). pii: 1801491. doi: 10.1183/13993003.01491-2018. Print 2018 Dec. No abstract available.

PMID:
30262578
19.

Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals.

Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, Ost DE, Punjabi NM, Schatz M, Smyth AR, Stewart PW, Suissa S, Adjei AA, Akdis CA, Azoulay É, Bakker J, Ballas ZK, Bardin PG, Barreiro E, Bellomo R, Bernstein JA, Brusasco V, Buchman TG, Chokroverty S, Collop NA, Crapo JD, Fitzgerald DA, Hale L, Hart N, Herth FJ, Iwashyna TJ, Jenkins G, Kolb M, Marks GB, Mazzone P, Moorman JR, Murphy TM, Noah TL, Reynolds P, Riemann D, Russell RE, Sheikh A, Sotgiu G, Swenson ER, Szczesniak R, Szymusiak R, Teboul JL, Vincent JL.

Ann Am Thorac Soc. 2019 Jan;16(1):22-28. doi: 10.1513/AnnalsATS.201808-564PS. No abstract available. Erratum in: Ann Am Thorac Soc. 2019 Feb;16(2):283.

PMID:
30230362
20.

Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Flume PA, Chalmers JD, Olivier KN.

Lancet. 2018 Sep 8;392(10150):880-890. doi: 10.1016/S0140-6736(18)31767-7. Review.

PMID:
30215383
21.

The future of accreditation of continuing medical education (CME)-continuing professional development (CPD) in Europe: harmonisation through dialogue and consensus.

de Andrade F, Griebenow R, Costello RW, Guenova M, Schaefer R, Chalmers JD, Tichelli A, Raguz D, Stein J.

J Eur CME. 2018 Sep 3;7(1):1506202. doi: 10.1080/21614083.2018.1506202. eCollection 2018.

22.

Treatable traits in bronchiectasis.

Boaventura R, Sibila O, Agusti A, Chalmers JD.

Eur Respir J. 2018 Sep 6;52(3). pii: 1801269. doi: 10.1183/13993003.01269-2018. Print 2018 Sep. No abstract available.

PMID:
30190263
23.

The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol.

Aliberti S, Codecasa LR, Gori A, Sotgiu G, Spotti M, Di Biagio A, Calcagno A, Nardini S, Assael BM, Tortoli E, Besozzi G, Ferrarese M, Matteelli A, Girardi E, De Lorenzo S, Seia M, Gramegna A, Del Prato B, Terranova L, Oriano M, Sverzellati N, Mirsaeidi M, Chalmers JD, Haworth CS, Loebinger MR, Aksamit T, Winthrop K, Ringshausen FC, Previdi G, Blasi F; IRENE Network.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):33. doi: 10.1186/s40248-018-0141-8. eCollection 2018.

24.

Get together to increase awareness in bronchiectasis: a report of the 2nd World Bronchiectasis Conference.

Aliberti S, Chalmers JD.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):28. doi: 10.1186/s40248-018-0138-3. eCollection 2018. No abstract available.

25.

Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis.

Contarini M, Shoemark A, Rademacher J, Finch S, Gramegna A, Gaffuri M, Roncoroni L, Seia M, Ringshausen FC, Welte T, Blasi F, Aliberti S, Chalmers JD.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):26. doi: 10.1186/s40248-018-0143-6. eCollection 2018. Review.

26.

A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk.

McDonnell MJ, O'Toole D, Ward C, Pearson JP, Lordan JL, De Soyza A, Loebinger M, Chalmers JD, Laffey JG, Rutherford RM.

Respir Med. 2018 Aug;141:132-143. doi: 10.1016/j.rmed.2018.06.031. Epub 2018 Jun 30. Review.

PMID:
30053958
27.

The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions.

Polverino E, Dimakou K, Hurst J, Martinez-Garcia MA, Miravitlles M, Paggiaro P, Shteinberg M, Aliberti S, Chalmers JD.

Eur Respir J. 2018 Sep 15;52(3). pii: 1800328. doi: 10.1183/13993003.00328-2018. Print 2018 Sep. Review.

PMID:
30049739
28.

Bronchiectasis: a case-based approach to investigation and management.

Contarini M, Finch S, Chalmers JD.

Eur Respir Rev. 2018 Jul 11;27(149). pii: 180016. doi: 10.1183/16000617.0016-2018. Print 2018 Sep 30. Review.

29.

Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients.

Restrepo MI, Babu BL, Reyes LF, Chalmers JD, Soni NJ, Sibila O, Faverio P, Cilloniz C, Rodriguez-Cintron W, Aliberti S; GLIMP.

Eur Respir J. 2018 Aug 9;52(2). pii: 1701190. doi: 10.1183/13993003.01190-2017. Print 2018 Aug.

PMID:
29976651
30.

The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation: a case-crossover analysis.

Goeminne PC, Cox B, Finch S, Loebinger MR, Bedi P, Hill AT, Fardon TC, de Hoogh K, Nawrot TS, Chalmers JD.

Eur Respir J. 2018 Jul 27;52(1). pii: 1702557. doi: 10.1183/13993003.02557-2017. Print 2018 Jul.

PMID:
29903857
31.

Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study.

Mac Aogáin M, Chandrasekaran R, Lim AYH, Low TB, Tan GL, Hassan T, Ong TH, Hui Qi Ng A, Bertrand D, Koh JY, Pang SL, Lee ZY, Gwee XW, Martinus C, Sio YY, Matta SA, Chew FT, Keir HR, Connolly JE, Abisheganaden JA, Koh MS, Nagarajan N, Chalmers JD, Chotirmall SH.

Eur Respir J. 2018 Jul 27;52(1). pii: 1800766. doi: 10.1183/13993003.00766-2018. Print 2018 Jul.

32.

Severe Paediatric Asthma Collaborative in Europe (SPACE): protocol for a European registry.

Liu NM, van Aalderen W, Carlsen KCL, Coleman C, Chalmers JD, Cunningham S, Fernandes RM, Fleming LJ, Gappa M, Karadag B, Midulla F, Pijnenburg MWH, Rutjes NW, Rusconi F, Grigg J.

Breathe (Sheff). 2018 Jun;14(2):93-98. doi: 10.1183/20734735.002018. Review.

33.

Continuous versus intermittent antibiotics for bronchiectasis.

Donovan T, Felix LM, Chalmers JD, Milan SJ, Mathioudakis AG, Spencer S.

Cochrane Database Syst Rev. 2018 Jun 3;6:CD012733. doi: 10.1002/14651858.CD012733.pub2. Review.

PMID:
29860722
34.

"The missing ingredient": the patient perspective of health related quality of life in bronchiectasis: a qualitative study.

Dudgeon EK, Crichton M, Chalmers JD.

BMC Pulm Med. 2018 May 22;18(1):81. doi: 10.1186/s12890-018-0631-7.

35.

Bronchiectasis: an emerging global epidemic.

Chotirmall SH, Chalmers JD.

BMC Pulm Med. 2018 May 22;18(1):76. doi: 10.1186/s12890-018-0629-1.

36.

Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Chandrasekaran R, Mac Aogáin M, Chalmers JD, Elborn SJ, Chotirmall SH.

BMC Pulm Med. 2018 May 22;18(1):83. doi: 10.1186/s12890-018-0638-0. Review.

37.

Predicting outcomes in bronchiectasis.

Mendes MA, Chalmers JD.

Pulmonology. 2018 May - Jun;24(3):146-148. doi: 10.1016/j.pulmoe.2018.04.004. No abstract available.

39.

Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.

Torres A, Cillóniz C, Blasi F, Chalmers JD, Gaillat J, Dartois N, Schmitt HJ, Welte T.

Respir Med. 2018 Apr;137:6-13. doi: 10.1016/j.rmed.2018.02.007. Epub 2018 Feb 19. Review.

PMID:
29605214
40.

Oral versus inhaled antibiotics for bronchiectasis.

Spencer S, Felix LM, Milan SJ, Normansell R, Goeminne PC, Chalmers JD, Donovan T.

Cochrane Database Syst Rev. 2018 Mar 27;3:CD012579. doi: 10.1002/14651858.CD012579.pub2. Review.

PMID:
29587336
41.

The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators.

Wai DCC, Szyszka TN, Campbell AE, Kwong C, Wilkinson-White LE, Silva APG, Low JKK, Kwan AH, Gamsjaeger R, Chalmers JD, Patrick WM, Lu B, Vakoc CR, Blobel GA, Mackay JP.

J Biol Chem. 2018 May 11;293(19):7160-7175. doi: 10.1074/jbc.RA117.000678. Epub 2018 Mar 22.

PMID:
29567837
42.

Macrolide antibiotics for bronchiectasis.

Kelly C, Chalmers JD, Crossingham I, Relph N, Felix LM, Evans DJ, Milan SJ, Spencer S.

Cochrane Database Syst Rev. 2018 Mar 15;3:CD012406. doi: 10.1002/14651858.CD012406.pub2. Review.

PMID:
29543980
43.

Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.

Suarez-Cuartin G, Giner J, Merino JL, Rodrigo-Troyano A, Feliu A, Perea L, Sanchez-Reus F, Castillo D, Plaza V, Chalmers JD, Sibila O.

Respir Med. 2018 Mar;136:111-117. doi: 10.1016/j.rmed.2018.02.008. Epub 2018 Feb 13.

PMID:
29501241
44.

Bronchiectasis Exacerbations Are Heart-Breaking.

Chalmers JD.

Ann Am Thorac Soc. 2018 Mar;15(3):301-303. doi: 10.1513/AnnalsATS.201710-832ED. No abstract available.

PMID:
29493334
45.

Bronchiectasis: new therapies and new perspectives.

Chalmers JD, Chotirmall SH.

Lancet Respir Med. 2018 Sep;6(9):715-726. doi: 10.1016/S2213-2600(18)30053-5. Epub 2018 Feb 23. Review.

PMID:
29478908
46.

Rebuttal From Dr Chalmers.

Chalmers JD.

Chest. 2018 Apr;153(4):785-786. doi: 10.1016/j.chest.2018.01.036. Epub 2018 Feb 21. No abstract available.

PMID:
29474808
47.

POINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV1 < 50% Predicted) COPD? Yes.

Chalmers JD.

Chest. 2018 Apr;153(4):778-782. doi: 10.1016/j.chest.2018.01.029. Epub 2018 Feb 21. No abstract available.

PMID:
29474807
48.

The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.

Araújo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Stone G, Trautmann M, Davis A, Dimakou K, Polverino E, De Soyza A, McDonnell MJ, Chalmers JD.

Eur Respir J. 2018 Jan 31;51(2). pii: 1701953. doi: 10.1183/13993003.01953-2017. Print 2018 Feb.

PMID:
29386336
49.

RESPIRE: breathing new life into bronchiectasis.

Chotirmall SH, Chalmers JD.

Eur Respir J. 2018 Jan 25;51(1). pii: 1702444. doi: 10.1183/13993003.02444-2017. Print 2018 Jan. No abstract available.

PMID:
29371393
50.

Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis.

Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Gerlinger C, Sotgiu G, Operschall E, Rutherford RM, Dimakou K, Polverino E, De Soyza A, McDonnell MJ.

Am J Respir Crit Care Med. 2018 Jun 1;197(11):1410-1420. doi: 10.1164/rccm.201711-2202OC.

PMID:
29357265

Supplemental Content

Loading ...
Support Center